Apn Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 1.43 M
- Company Age 23 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 1366.54%
- Ebitda 29.19%
- Net Worth 13.38%
- Total Assets 10.57%
About Apn Biotech
Apn Biotech Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 August 2001 and has a history of 23 years and five months. Its registered office is in Sirsa, Haryana, India.
The Corporate was formerly known as Nikhil Anand Prakash And Trading Company Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.43 M, as per Ministry of Corporate Affairs (MCA) records.
Naman Gupta and Ashutosh Gupta serve as directors at the Company.
Company Details
-
Location
Sirsa, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U47721HR2001PTC034733
-
Company No.
034733
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Aug 2001
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Apn Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naman Gupta
|
Director | 29-Dec-2023 | Current |
|
Ashutosh Gupta
|
Director | 02-Dec-2022 | Current |
Financial Performance of Apn Biotech.
Apn Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1366.54% increase in profit. The company's net worth Soared by an impressive increase of 13.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apn Biotech?
In 2023, Apn Biotech had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sunrise Structures & Developers Private LimitedAshutosh Gupta is a mutual person
-
Isshaan Healthcare Private LimitedAshutosh Gupta is a mutual person
-
Pks Buildmart Private LimitedAshutosh Gupta is a mutual person
-
Craanford Pharma Private LimitedNaman Gupta and Ashutosh Gupta are mutual person
-
Avn Buildcon Private Limited
Naman Gupta is a mutual person
-
Volga Agricare (India) Private Limited
Ashutosh Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Apn Biotech?
Unlock and access historical data on people associated with Apn Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apn Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apn Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
